Skip to main content
SpringerLink
Log in

Adalimumab/itraconazole/rifampicin

Pulmonary tuberculosis, pulmonary histoplasmosis and subtherapeutic itraconazole levels due to drug interaction: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Gianarakis M, et al. Double Trouble: Concomitant Tuberculosis and Histoplasmosis Following TNF-alpha Inhibitor Treatment for Crohn's Disease. American Journal of Gastroenterology 117 (Suppl. 2): S1789 abstr. S2717, No. 10, Oct 2022. Available from: URL: http://doi.org/10.14309/01.ajg.0000867508.41904.a1 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/itraconazole/rifampicin. Reactions Weekly 1959, 35 (2023). https://doi.org/10.1007/s40278-023-40207-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-40207-5

Search

Navigation